Latest news with #URD
Time of India
12-05-2025
- Business
- Time of India
Electricity bills of power consumers in Delhi to be hiked by 7-10% in May-June period
The electricity bills of power consumers in Delhi will be hiked by 7-10 per cent in the May-June period due to revision of PPAC charged by the discoms, officials said on Sunday. The power purchase adjustment cost (PPAC) refers to rise in fuel (coal, gas) costs incurred by the generation companies which is recovered by discoms from the consumers. It is calculated as percentage of fixed charge and energy charge (units consumed) components of the electricity bill. The Delhi Electricity Regulatory Commission (DERC) in its separate orders earlier this month allowed the three discoms to recover the PPAC of third quarter of 2024-25 in the May-June 2024 period. The PPAC allowed are 7.25 per cent for BRPL, 8.11 per cent for BYPL and 10.47 percent for TPDDL. No reaction was available from the discoms on the increase in PPAC allowed by the DERC. The United Residents of Delhi (URD), an umbrella body of residents welfare associations in the city, slammed the move as "arbitrary". "The process under which PPAC charges have been imposed on the people of Delhi by DERC is legally wrong," said a statement from URD general secretary Saurabh Gandhi. No reaction was immediately available from the DERC over the allegation. "For the last several years, the Commission has been benefiting the power companies from other items. Now we had great hope from the Commission that has been formed that it will complete the work of tariff determination by following the prescribed procedure, but this Commission conducted a virtual public hearing where not enough time was given to the stakeholders to state their case," Gandhi claimed. It is also a fact that the PPAC claimed by various discoms and the PPAC awarded by DERC is different. For BRPL it is 7.25 per cent, for BYPL it is 8.11 per cent and for TPDDL it is 10.47 percent, he said. "Since the cost of fuel surcharge under u/s 64(4) is almost the same for all discoms, the percentage differential tariff should have been the same," Gandhi added. Discom sources defended the PPAC and said that it was in line with the DERC's regulations orders issued in different time periods for different discoms. "The PPAC is recovered to ensure timely pass through of power purchase cost, which is dependent upon the coal and gas prices, to the consumer. It is a statutory mandate and the process is very transparent and validated by the regulator," they said. Without PPAC, discoms will have liquidity stress and they will have no money to pay the power generation companies, sources added.
Economic Times
12-05-2025
- Business
- Economic Times
Electricity bills of power consumers in Delhi to be hiked by 7-10% in May-June period
Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Popular in Energy 1. Adani Power wins bid to supply 1500 MW thermal power to Uttar Pradesh The electricity bills of power consumers in Delhi will be hiked by 7-10 per cent in the May-June period due to revision of PPAC charged by the discoms, officials said on Sunday. The power purchase adjustment cost (PPAC) refers to rise in fuel (coal, gas) costs incurred by the generation companies which is recovered by discoms from the is calculated as percentage of fixed charge and energy charge (units consumed) components of the electricity Delhi Electricity Regulatory Commission (DERC) in its separate orders earlier this month allowed the three discoms to recover the PPAC of third quarter of 2024-25 in the May-June 2024 PPAC allowed are 7.25 per cent for BRPL, 8.11 per cent for BYPL and 10.47 percent for reaction was available from the discoms on the increase in PPAC allowed by the United Residents of Delhi (URD), an umbrella body of residents welfare associations in the city, slammed the move as "arbitrary"."The process under which PPAC charges have been imposed on the people of Delhi by DERC is legally wrong," said a statement from URD general secretary Saurabh reaction was immediately available from the DERC over the allegation."For the last several years, the Commission has been benefiting the power companies from other items. Now we had great hope from the Commission that has been formed that it will complete the work of tariff determination by following the prescribed procedure, but this Commission conducted a virtual public hearing where not enough time was given to the stakeholders to state their case," Gandhi is also a fact that the PPAC claimed by various discoms and the PPAC awarded by DERC is different. For BRPL it is 7.25 per cent, for BYPL it is 8.11 per cent and for TPDDL it is 10.47 percent, he said."Since the cost of fuel surcharge under u/s 64(4) is almost the same for all discoms, the percentage differential tariff should have been the same," Gandhi sources defended the PPAC and said that it was in line with the DERC's regulations orders issued in different time periods for different discoms."The PPAC is recovered to ensure timely pass through of power purchase cost, which is dependent upon the coal and gas prices, to the consumer. It is a statutory mandate and the process is very transparent and validated by the regulator," they PPAC, discoms will have liquidity stress and they will have no money to pay the power generation companies, sources added.
The Hindu
11-05-2025
- Business
- The Hindu
Power bills likely to rise by 7-10%; Oppn., residents slam move
Electricity bills in Delhi are likely to increase by 7-10% during the May-June billing cycle due to a revision in the power purchase adjustment cost (PPAC), which is a surcharge levied on consumers to offset power procurement costs incurred by discoms due to a rise in fuel costs, officials said on Sunday. The Delhi Electricity Regulatory Commission (DERC) earlier this month had permitted three discoms to recover costs linked to fuel price fluctuations during the third quarter of 2024-25. The approved PPAC rates are 7.25% for BSES Rajdhani Power Limited, 8.11% for BSES Yamuna Power Limited, and 10.47% for Tata Power Delhi Distribution Limited. Although there was no immediate response from the BJP-led Delhi government, the Congress's Delhi unit slammed the ruling party, claiming that this is yet another 'financial blow to residents' of the city. 'The Rekha Gupta government is emulating the corrupt [Arvind] Kejriwal government by increasing the PPAC surcharge,' Delhi Congress president Devender Yadav said, recalling that the BJP had earlier protested against similar hikes during the previous AAP government. The United Residents of Delhi (URD), a body that represents Resident Welfare Associations in the city, denounced the move, terming it 'arbitrary'. 'The process under which PPAC charges have been imposed on the people of Delhi by DERC is legally wrong,' said URD general secretary Saurabh Gandhi. Meanwhile, discom sources defended the PPAC and said it was in line with DERC's orders. 'The PPAC is recovered to ensure timely passing on of power purchase cost, which is dependent upon coal and gas prices, to the consumer. It is a statutory mandate and the process is very transparent and validated by the regulator,' a source said. Without PPAC, discoms will have liquidity stress and no money to pay the power generation companies, the source added. (With inputs from The Hindu Bureau)
&w=3840&q=100)
Business Standard
11-05-2025
- Business
- Business Standard
Electricity bills of Delhi consumers to be hiked by 7-10% in May-Jun period
The power purchase adjustment cost (PPAC) refers to rise in fuel (coal, gas) costs incurred by the generation companies which is recovered by discoms from the consumers Press Trust of India New Delhi The electricity bills of power consumers in Delhi will be hiked by 7-10 per cent in the May-June period due to revision of PPAC charged by the discoms, officials said on Sunday. The power purchase adjustment cost (PPAC) refers to rise in fuel (coal, gas) costs incurred by the generation companies which is recovered by discoms from the consumers. It is calculated as percentage of fixed charge and energy charge (units consumed) components of the electricity bill. The Delhi Electricity Regulatory Commission (DERC) in its separate orders earlier this month allowed the three discoms to recover the PPAC of third quarter of 2024-25 in the May-June 2024 period. The PPAC allowed are 7.25 per cent for BRPL, 8.11 per cent for BYPL and 10.47 percent for TPDDL. No reaction was available from the discoms on the increase in PPAC allowed by the DERC. The United Residents of Delhi (URD), an umbrella body of residents welfare associations in the city, slammed the move as "arbitrary". "The process under which PPAC charges have been imposed on the people of Delhi by DERC is legally wrong," said a statement from URD general secretary Saurabh Gandhi. No reaction was immediately available from the DERC over the allegation. "For the last several years, the Commission has been benefiting the power companies from other items. Now we had great hope from the Commission that has been formed that it will complete the work of tariff determination by following the prescribed procedure, but this Commission conducted a virtual public hearing where not enough time was given to the stakeholders to state their case," Gandhi claimed. It is also a fact that the PPAC claimed by various discoms and the PPAC awarded by DERC is different. For BRPL it is 7.25 per cent, for BYPL it is 8.11 per cent and for TPDDL it is 10.47 percent, he said. "Since the cost of fuel surcharge under u/s 64(4) is almost the same for all discoms, the percentage differential tariff should have been the same," Gandhi added. Discom sources defended the PPAC and said that it was in line with the DERC's regulations orders issued in different time periods for different discoms. "The PPAC is recovered to ensure timely pass through of power purchase cost, which is dependent upon the coal and gas prices, to the consumer. It is a statutory mandate and the process is very transparent and validated by the regulator," they said. Without PPAC, discoms will have liquidity stress and they will have no money to pay the power generation companies, sources added. (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Business Wire
29-04-2025
- Business
- Business Wire
Aelis Farma: Availability of the 2024 Universal Registration Document
BORDEAUX, France--(BUSINESS WIRE)--Regulatory News: Aelis Farma (ISIN: FR0014007ZB4 – Ticker: AELIS), a clinical-stage biopharmaceutical company specializing in the development of treatments for brain and peripheral diseases involving the CB 1 receptor, today announces the publication of its 2024 Universal Registration Document (URD) as filed with the French Financial Markets Authority (Autorité des Marchés Financiers (AMF)) on April 28, 2025, under number D.25-0314. The Universal Registration Document 2024 includes in particular: The 2024 annual financial report; The statutory auditor's reports; Information on the statutory auditor's fees; Information relating to corporate social responsibility. The URD can be consulted and downloaded on the Company's website under the heading Investors / Documentation, as well as on the AMF website ( Financial Agenda: *** About AELIS FARMA Founded in Bordeaux in 2013, Aelis Farma is a biopharmaceutical company that is developing a new class of drugs, the Signaling Specific inhibitors of the CB 1 receptor of the endocannabinoid system (CB 1 -SSi). CB 1 -SSi have been developed by Aelis Farma based on the discovery of a natural regulatory mechanism of CB 1 hyperactivity made by the team led by Dr Pier Vincenzo Piazza, the Company's CEO, when he was the director of the Neurocentre Magendie of INSERM in Bordeaux. By mimicking this natural mechanism, CB 1 -SSi appear to selectively inhibit the disease-related activity of the CB 1 receptor without disrupting its normal physiological activity. CB 1 -SSi have consequently the potential to provide new safe treatments for several brain and peripheral organ diseases. Aelis Farma currently has two first-in-class clinical-stage drug candidates. AEF0117 for the treatment of cannabis use disorders (CUD), that has shown to be able to decrease cannabis use across two studies. AEF0217 for cognitive disorders, which has shown in a Phase 1/2 to be safe and able to improve adaptive behaviour in young adults with Down syndrome (Trisomy 21). The clinical results obtained with these 2 molecules have confirmed the pharmacological activity of CB 1 -SSi in humans. The Company also has a portfolio of new innovative CB 1 -SSi for the treatment of other disorders associated with a dysregulation of the activity of the CB 1 receptor, including diseases involving peripheral organs, such as obesity and related metabolic conditions. The different drugs developed by the company belong to the same general pharmacological class, the CB 1 -SSi, but have distinct functional effects allowing to target different types of dysregulations of the CB 1 receptor and guaranteeing that the different compounds are not substitutable one with the others. Aelis Farma draws on the talents of more than 25 highly qualified employees. For more information, visit and follow us on LinkedIn and Twitter. ISIN: FR0014007ZB4 Ticker: AELIS B Compartment of Euronext Paris Disclaimer Forward-looking statements Some information contained in this press release is forward-looking statements, not historical data. These forward-looking statements are based on current beliefs, expectations, and assumptions, including, but not limited to, assumptions about Aelis Farma's current and future strategy and the environment in which Aelis Farma operates. They involve known and unknown risks, uncertainties, and other factors, which may cause actual results, performance, achievements, or industry results or other events, to differ materially from those described or implied by such forward-looking statements. These risks and uncertainties include those set out and described in detail in Chapter 3 "Risk Factors" of Aelis Farma's Universal Registration Document approved by the Autorité des Marchés Financiers on April 28, 2025, under number D.25-0314. These forward-looking statements are made only as of the date of this press release and Aelis Farma expressly disclaims any obligation or undertaking to release any updates or corrections to the forward-looking statements included in this press release to reflect any change in expectations or events, conditions, or circumstances on which any such forward-looking statement is based. Forward-looking information and statements are not guarantees of future performance and are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond Aelis Farma's control. Actual results could differ materially from those described in, or implied or projected by, forward-looking information and statements.
